tiprankstipranks
Trending News
More News >
Dr. Lal PathLabs Limited (IN:LALPATHLAB)
:LALPATHLAB
India Market

Dr. Lal PathLabs Limited (LALPATHLAB) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

LALPATHLAB Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Dr.
Lal PathLabs Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LALPATHLAB Stock 12 Month Forecast

There Are No Analyst Ratings for IN:LALPATHLAB In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

LALPATHLAB Financial Forecast

LALPATHLAB Earnings Forecast

Next quarter’s earnings estimate for LALPATHLAB is ₹8.02 with a range of ₹6.90 to ₹13.10. The previous quarter’s EPS was ₹9.00. LALPATHLAB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year LALPATHLAB has Performed in-line its overall industry.
Next quarter’s earnings estimate for LALPATHLAB is ₹8.02 with a range of ₹6.90 to ₹13.10. The previous quarter’s EPS was ₹9.00. LALPATHLAB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year LALPATHLAB has Performed in-line its overall industry.

LALPATHLAB Sales Forecast

Next quarter’s sales forecast for LALPATHLAB is ₹6.67B with a range of ₹6.60B to ₹6.73B. The previous quarter’s sales results were ₹7.31B. LALPATHLAB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year LALPATHLAB has Performed in-line its overall industry.
Next quarter’s sales forecast for LALPATHLAB is ₹6.67B with a range of ₹6.60B to ₹6.73B. The previous quarter’s sales results were ₹7.31B. LALPATHLAB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year LALPATHLAB has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Nomura
₹3,560₹3,870
Buy
162.74%
Upside
Reiterated
08/04/25
Nomura Remains a Buy on Dr. Lal PathLabs Limited (LALPATHLAB)
ICICI Securities Analyst forecast on IN:LALPATHLAB
ICICI Securities
ICICI Securities
₹2,900₹3,000
Hold
103.67%
Upside
Reiterated
08/01/25
Dr. Lal PathLabs Limited (LALPATHLAB) Gets a Hold from ICICI Securities
Citi
₹2,850₹2,700
Sell
83.31%
Upside
Reiterated
04/27/25
Dr Lal PathLabs Ltd (DLPL:IN) PT Lowered to INR2,700 at CitiCiti analyst Vivek Agrawal lowered the price target on Dr Lal PathLabs Ltd (DLPL:IN) to INR2,700.00 (from INR2,850.00) while maintaining a Sell rating.
Goldman Sachs Analyst forecast on IN:LALPATHLAB
Goldman Sachs
Goldman Sachs
₹2,675₹2,650
Sell
79.91%
Upside
Reiterated
04/26/25
Dr Lal PathLabs Ltd (DLPL:IN) PT Lowered to INR2,650 at Goldman SachsGoldman Sachs analyst Shyam Srinivasan lowered the price target on Dr Lal PathLabs Ltd (DLPL:IN) to INR2,650.00 (from INR2,675.00) while maintaining a Sell rating.
CLSA
₹3,110₹3,240
Buy
119.97%
Upside
Upgraded
01/23/25
CLSA Upgrades Dr Lal PathLabs Ltd (DLPL:IN) to Outperform (2)CLSA analyst Kunal Lakhan upgraded Dr Lal PathLabs Ltd (DLPL:IN) from Hold (3) to Outperform (2) with a price target of INR3,240.00 (from INR3,110.00).
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Nomura
₹3,560₹3,870
Buy
162.74%
Upside
Reiterated
08/04/25
Nomura Remains a Buy on Dr. Lal PathLabs Limited (LALPATHLAB)
ICICI Securities Analyst forecast on IN:LALPATHLAB
ICICI Securities
ICICI Securities
₹2,900₹3,000
Hold
103.67%
Upside
Reiterated
08/01/25
Dr. Lal PathLabs Limited (LALPATHLAB) Gets a Hold from ICICI Securities
Citi
₹2,850₹2,700
Sell
83.31%
Upside
Reiterated
04/27/25
Dr Lal PathLabs Ltd (DLPL:IN) PT Lowered to INR2,700 at CitiCiti analyst Vivek Agrawal lowered the price target on Dr Lal PathLabs Ltd (DLPL:IN) to INR2,700.00 (from INR2,850.00) while maintaining a Sell rating.
Goldman Sachs Analyst forecast on IN:LALPATHLAB
Goldman Sachs
Goldman Sachs
₹2,675₹2,650
Sell
79.91%
Upside
Reiterated
04/26/25
Dr Lal PathLabs Ltd (DLPL:IN) PT Lowered to INR2,650 at Goldman SachsGoldman Sachs analyst Shyam Srinivasan lowered the price target on Dr Lal PathLabs Ltd (DLPL:IN) to INR2,650.00 (from INR2,675.00) while maintaining a Sell rating.
CLSA
₹3,110₹3,240
Buy
119.97%
Upside
Upgraded
01/23/25
CLSA Upgrades Dr Lal PathLabs Ltd (DLPL:IN) to Outperform (2)CLSA analyst Kunal Lakhan upgraded Dr Lal PathLabs Ltd (DLPL:IN) from Hold (3) to Outperform (2) with a price target of INR3,240.00 (from INR3,110.00).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dr. Lal PathLabs Limited

3 Months
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
+2.50%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +2.50% per trade.
1 Year
Success Rate
2/3 ratings generated profit
67%
Average Return
+2.20%
reiterated a buy rating 5 months ago
Copying Saion Mukherjee's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +2.20% per trade.
2 Years
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
+2.20%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +2.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LALPATHLAB Analyst Recommendation Trends

Rating
Jan 25
Apr 25
Jul 25
Aug 25
Oct 25
Strong Buy
2
3
3
2
1
Buy
0
0
0
0
0
Hold
1
1
2
2
9
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
5
4
10
In the current month, LALPATHLAB has received 1 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. LALPATHLAB average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

LALPATHLAB Stock Forecast FAQ

What is IN:LALPATHLAB’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:LALPATHLAB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:LALPATHLAB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Dr. Lal PathLabs Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Dr. Lal PathLabs Limited’s share price target?
      Currently, no data Available
      What do analysts say about Dr. Lal PathLabs Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Dr. Lal PathLabs Limited?
      To buy shares of IN:LALPATHLAB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.